Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in China / NCT06347679
Recruiting Not applicable

Effects of Aromatherapy on Anxiety and Pain During Dental Treatment in Adults

NCT06347679 · tracked via the Priya Life Science China tracker
Sponsor
Sichuan University
Phase
Not applicable
Started
2024-05-01
Last updated
2025-05-16

Condition(s) studied

Dental Anxiety

Investigational drug(s) / intervention(s)

Aroma diffuser with single-note sweet orange essential oilAroma diffuser with single-note tea tree essential oilAroma diffuser with water

Aroma diffuser with single-note sweet orange essential oil: In a space of 3\*4\*2.6 cubic meters, positioned 10 cm away from the patient, add 4-6 drops (each drop being 0.05 ml) of 100% concentration single-note sweet orange essential oil into the aroma diffuser reservoir containing 120 ml of water.

Aroma diffuser with single-note tea tree essential oil: In a space of 3\*4\*2.6 cubic meters, positioned 10 cm away from the patient, add 4-6 drops (each drop being 0.05 ml) of 100% concentration single-note tea tree essential oil into the aroma diffuser reservoir containing 120 ml of water.

Aroma diffuser with water: In a space of 3\*4\*2.6 cubic meters, positioned 10 cm away from the patient, add 4-6 drops (each drop being 0.05 ml) of water into the aroma diffuser reservoir containing 120 ml of water.

Study summary

Dental anxiety is a common problem in dental care. The aim of this protocol is to evaluate the effect of orange and tea essential oil for the control of anxiety and pain in adults during dental treatments.

Eligibility

Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Patients who need dental treatment, such as resin filling, root canal treatment, periodontal initial treatment, tooth extraction, etc. * Be able to understand the purpose of the study and volunteer to take part in the study. * Be able to complete all assessments and follow-up during the study. Exclusion Criteria: * Patients who are allergic to the ingredients of the essential oils used in the experiment or to the materials used in the dental treatment. * Patients who underwent only an oral examination. * Patients with severe heart disease, hypertension, respiratory disease, or other systemic conditions that were not eligible for trial participation. * Pregnant or lactating women. * People with depressive symptoms, anxiety disorders or other mental illnesses that affect their mood state. * People who are using sedative or analgesic drugs. * Recent or current users of essential oil. * Any circumstances considered by the investigator to be inappropriate for participation in this study.

Primary outcome measure(s)

  • Anxiety scale 1 - Modified Dental Anxiety Scale (MDAS) — 5 minutes before operation/during operation (immediately after the most painful procedure)/immediately after operation
    The Modified Dental Anxiety Scale (MDAS) consists of 4 questions each with a 5 category rating scale, ranging from 'not anxious' to 'extremely anxious', hence, the total score varies from 4 to 20, with higher obtained scores describing more elevated levels of dental anxiety. MDAS is recorded before, during and after operation.
  • Pain scale - Visual Analog Scale (VAS) — 5 minutes before operation/during operation (immediately after the most painful procedure)/immediately after operation
    The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between "no pain" and "worst pain." VAS is recorded before, during and after operation.

Trial sites (1)

FacilityCityRegionStatus
West China Hospital of Stomatology SIchuan University Chengdu Sichuan Recruiting

More Sichuan University trials in China

A Study of BL-B01D1 and Almonertinib in Patients With Resectable EGFR+ Stage II-IIIB NSCLC Recruiting
Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma Recruiting
Oncolytic Virus in Esophageal Squamous Cell Carcinoma Recruiting
Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer Recruiting
A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06347679 on ClinicalTrials.gov ↗ ← All trials in China